Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects

Transfusion

Volumn 43, Issue 10, 2003, Pages 1414-1422

  Bolan, Charles D ^a   Cecco, Stacey A ^b   Yau, Yu Ying ^b   Wesley, Robert A ^b   Oblitas, Jaime M ^b   Rehak, Nadja N ^b   Leitman, Susan F ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CALCIUM ION; CITRIC ACID; OSTEOCALCIN; PARATHYROID HORMONE; TUMS; MAGNESIUM; PLASMA PROTEIN; SERUM ALBUMIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; BONE DENSITY; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAGNESIUM EXCRETION; MALE; METABOLIC REGULATION; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPHERESIS; URINARY EXCRETION; AGED; BLOOD; MIDDLE AGED; ORAL DRUG ADMINISTRATION; URINE;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PROTEINS; CALCIUM; CALCIUM CARBONATE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PLATELETPHERESIS; SERUM ALBUMIN;

EID: 0142103774     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00513.x     Document Type: Article

References (23)

1. Mishler JM, Janes AW, Lowes B, et al. Utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. I. Assessment of donor effects. Br J Haematol 1976;34:387-94.
2. Huestis DW, Fletcher JL, White RF, Price MJ. Citrate anticoagulants for plateletpheresis. Transfusion 1977;17:151-5.
3. Olson PR, Cox C, McCullough J. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis. Vox Sang 1977;33:79-87.
4. Szymanski IO. Ionized calcium during plateletpheresis. Transfusion 1978;18:701-8.
5. Hester JP, McCullough J, Mishler JM, Szymanski IO. Dosage regimens for citrate anticoagulants. J Clin Apheresis 1983;1:149-57.
6. Hester JP, Ayyar R. Anticoagulation and electrolytes. J Clin Apheresis 1984;2:41-51.
7. Toffaletti J. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis. Transfusion 1983;23:471-5.
8. Toffaletti J, Nissenson R, Endres D, et al. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis. J Clin Endocrinol Metab 1985;60:874-9.
9. Mercan D, Bastin G, Lambermont M, Dupont E. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis. Transfusion 1997;37:418-22.
10. Bolan CD, Greer SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001;41:1165-71.
11. Simon TL, McLeod BC. Physiology of apheresis. In: McLeod BC, Price TH, Drew MJ, eds. Apheresis: principles and practice. Bethesda, MD: AABB Press, 1997:67-84.
12. Bolan CD, Wesley RA, Yau YY, et al. Randomized placebo controlled study of oral calcium supplementation in plateletpheresis. I. Effects on donor symptoms. Transfusion 2003;43:1403-13.
13. Sheikh MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-6.
14. Deroisy R, Zartarian M, Meurmans L, et al. Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 1997;16:249-53.
15. Harvey JA, Zobitz MM, Pak CY. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988;3:253-8.
16. Kishimoto M, Ohto H, Shikama Y, et al. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting. Transfusion 2002;42:1340-7.
17. Holick MF, Krane SM, et al. Calcium, phosphorus and bone metabolism: calcium-regulating hormones. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's, 13th ed. New York: McGraw-Hill, 1994:2137-50.
18. Brown EM. Physiology of calcium homeostasis. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids. Basic and clinical concepts, 2nd ed. San Diego: Academic Press, 2002:167-81.
19. Gundberg CM, Grant FD, Conlin PR, et al. Acute changes in serum osteocalcin during induced hypocalcemia in humans. J Clin Endocrinol Metab 1991;72:438-43.
20. Hock JM, Raisz LG, Canalis E. Parathryoid hormone. Anabolic and catabolic effects on bone and interactions with growth factors. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids. Basic and clinical concepts, 2nd ed. San Diego: Academic Press, 2002:183-98.
21. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
22. Silverberg SJ, Bilezikia JP. Parathyroid function and responsiveness in osteoporosis. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids. Basic and clinical concepts, 2nd ed. San Diego, Academic Press, 2002:843-52.
23. Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and responses to intravenous calcium administration during allogeneic peripheral blood stem cell donation. Transfusion 2002;42:935-46.